A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to <26 Years of Age.
Clinical trial NCT03135834 · COMPLETED
Trial details
- NCT number
- NCT03135834
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-24
- Primary completion
- 2022-10-25
- Enrollment
- 1610
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.